FDA Issues Warning Letter Over Production Lapses at Medline's Illinois Plant
Medline (MDLN) shares fell for the fourth consecutive session after receiving a warning letter from the FDA regarding manufacturing issues at its Illinois facility. The FDA cited multiple lapses, which could impact regulatory compliance and investor confidence.
Tickers: $MDLN